Provision of Luminex CE Marked OEM Consumables for SARS-CoV-2 Sequencing

About

Public Health England awarded a contract to Luminex Corporation for the provision of Luminex consumables proprietary to the MAGPIX xPONENT System IVD, supporting the Genomic Expansion Project across PHE laboratory network sites.

The consumables and kits are critical for SARS-CoV-2 sequencing protocols, offering a single-tube assay with freeze-dried reagents and long shelf life to detect 23 respiratory targets, compared to competitor multiplex assays requiring 4 to 5 assays for the same range.

The contract is PHE-wide, with Bristol and Cambridge as main sites, and may be extended by two further periods of up to 12 months.

The contract value is AUD 4,500,000.